Navigation Links
SAGE expands Therapeutic Advances series
Date:12/2/2010

London, UK (December 2, 2010) SAGE has extended its suite of Therapeutic Advances journals with the launch of a further two titles: Therapeutic Advances in Drug Safety, and Therapeutic Advances in Hematology.

Therapeutic Advances in Drug Safety covers novel and controversial aspects pertaining to the safe use of drugs in different age and ethnic patient groups, drug safety, therapeutic drug monitoring, pharmacoepidemiology, adverse drug reactions, drug interactions, pharmacokinetics, pharmacovigilance, medication/prescribing errors, risk management, ethics and regulation.

Therapeutic Advances in Hematology is for all professionals concerned with research and practice of hematology and is a forum for publishing original research and reviews in this area including research across all areas of hematology, including all of the malignant myeloid and lymphoid disorders (leukemia, myeloproliferative disorders, myelodysplasia, myeloma, lymphoma), red cell and platelet disorders, including transfusion medicine and clotting disorders, and any other relevant topic in the field.

Both international in scope, the journals follow the highly successful format of the existing nine Therapeutic Advances titles, offering rapid peer review and publication, with manuscripts published online within seven weeks of acceptance. Each journal publishes six issues per year and will be freely available on the award-winning SAGE Journals Online platform for the first three years of publication.

"We are delighted to expand the Therapeutic Advances series to cover these vital areas of medical research and practice" said Tessa Picknett, Associate Director and Publisher, STM Journals. "Our continuing aim is to rapidly publish high-quality clinically relevant, peer-reviewed original research and reviews, written by highly respected authors for busy specialists and other health professionals."


'/>"/>

Contact: Jayne Fairley
Jayne.fairley@sagepub.co.uk
020-732-48719
SAGE Publications UK
Source:Eurekalert

Page: 1

Related biology news :

1. National Science Foundation grant expands UMCES oyster research
2. Research-based undergraduate course expands beyond Washington University
3. UNC expands brain imaging study of infants at risk for autism
4. Stowers Institutes Linheng Li Lab expands understanding of bone marrow stem cell niche
5. Springer expands its portfolio in plant sciences with Phytoparasitica
6. SVOX Acquires Speech Processing Unit of Siemens AG, Expands Into Speech Recognition and Speech Dialog
7. New book expands field data available on orangutans
8. Fetal alcohol syndrome testing expands
9. NIH expands Human Microbiome Project; funds sequencing centers and disease projects
10. Fujitsu Expands Support for Ethernet Networks With New Additions to XG Switch Product Line
11. ID Analytics Expands Availability of On-Demand Identity Intelligence Solutions for the Government Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2016)... 16, 2016 The global ... to reach USD 1.83 billion by 2024, according ... Inc. Technological proliferation and increasing demand in commercial ... to drive the market growth.      ... The development of advanced multimodal techniques for biometric ...
(Date:6/9/2016)... June 9, 2016  Perkotek an innovation leader in attendance control systems is proud ... work hours, for employers to make sure the right employees are actually signing in, ... ... ... ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. and ... business relationship that includes integrating Syngrafii,s patented LongPen™ ... project. This collaboration will result in greater convenience ... credit union, while maintaining existing document workflow and ... ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... Raleigh, NC (PRWEB) , ... June 24, 2016 , ... ... find the most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings ... here to read it now. , Diagnostic biomarkers are signposts in the blood, ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator ... Members of the Class of 2016 were selected from a pool of 128 ... About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the ... at the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application ... team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our ...
Breaking Biology Technology: